This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Depressed individuals who reflexively attempt to dampen their initial emotional responses to reminders of their negative memories have a low tolerance for distressing emotional stimuli in general and may respond to stress in their daily lives with greater upticks in suicidal thoughts. A new study examined the relationship of the engagement of emotion regulation to real-world responses to stress in order to better understand stress-related increases in suicide risk in depression.
New York, NY Michael P. Milham , MD, PhD, the Chief Science Officer and the founding director of the Center for the Developing Brain at the Child Mind Institute, has been named to the 2024 list of Highly Cited Researchers . The list, compiled by Clarivate Plc , a leading global provider of transformative intelligence, features influential researchers at universities, research institutes and commercial organizations around the world who have demonstrated significant and broad influence in their
An insightful and inspiring anxiety guy podcast episode around finding your true self amongst the fog of anxiety awaits you today. Please enjoy below and don’t forget to leave a comment at the bottom on your biggest ‘more than anxiety moment’ from the episode. Welcome to another empowering episode of The Anxiety Guy Podcast , where we explore how to shift from self-criticism to self-compassion on your anxiety healing journey.
As we enter this season of gratitude, all of us at Montana Psychiatry & Brain Health Center want to take a moment to say how thankful we are for you. We hope this Thanksgiving brings moments of joy, connection, and comfort to you and your loved ones. To add a little extra cheer, weve included a Thanksgiving Family Fun Guide that you can print and share during your celebrations.
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Investigators evaluated whether data collected from a fitness tracker could be used to accurately detect mood episodes in people with bipolar disorder.
A Message from the WPA President With the successful conclusion of the World Psychiatric Associations (WPA) 24th World Congress of Psychiatry (WCP24) in Mexico City, I would like to take a moment, on behalf of the Organising and Scientific Committees, to express our gratitude to all participants, contributors, and partners who made this years congress a resounding success.
The current standard of care for psychosis is a diagnostic interview, but what if it could be diagnosed before the first symptom emerged? Researchers are pointing toward a potential biomarker in the brain that could lead to more timely interventions and personalized care.
The current standard of care for psychosis is a diagnostic interview, but what if it could be diagnosed before the first symptom emerged? Researchers are pointing toward a potential biomarker in the brain that could lead to more timely interventions and personalized care.
52
52
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
63 
Let's personalize your content